Endogenous low-level expression of the coxsackievirus and adenovirus receptor enables coxsackievirus B3 infection of RD cells

Journal of General Virology

Volumn 88, Issue 11, 2007, Pages 3031-3038

  Carson, Steven D ^a   Kim, Kyung Soo ^a   Pirruccello, Samuel J ^a   Tracy, Steven ^a   Chapman, Nora M ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; MESSENGER RNA; RECEPTOR ANTIBODY; VIRUS PROTEIN;

ARTICLE; CELL POPULATION; CELL TYPE; CONTROLLED STUDY; COXSACKIE VIRUS B3; COXSACKIE VIRUS INFECTION; CYTOPATHOGENIC EFFECT; HELA CELL; HUMAN; HUMAN CELL; IMMUNOHISTOLOGY; MONOLAYER CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPERNATANT; VIRUS RECOMBINANT; VIRUS REPLICATION; WESTERN BLOTTING;

CELL LINE; CYTOSOL; ENTEROVIRUS B, HUMAN; HUMANS; RECEPTORS, VIRUS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, VIRAL; VIRAL PROTEINS;

ADENOVIRIDAE; COXSACKIEVIRUS;

EID: 36249007499     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.82710-0     Document Type: Article

References (28)

1. Argo, E., Gimenez, B. & Cash, P. (1992). Non-cytopathic infection of rhabdomyosarcoma cells by coxsackie B5 virus. Arch Virol 126, 215-219.
2. Bergelson, J. M., Mohanty, J. G., Crowell, R. L., St John, N. F., Lublin, D. M. & Finberg, R. W. (1995). Coxsackievirus B3 adapted to growth in RD cells binds to decay accelerating factor (CD55). J Virol 69, 1903-1906.
3. Bergelson, J. M., Modlin, J. F., Wieland-Alter, W., Cunningham, J. A., Crowell, R. L. & Finberg, R. W. (1997). Clinical coxsackievirus B isolates differ from laboratory strains in their interaction with two cell surface receptors. J Infect Dis 175, 697-700.
4. Carson, S. D. (2000). Limited proteolysis of the coxsackievirus and adenovirus receptor (CAR) on HeLa cells exposed to trypsin. FEBS Lett 484, 149-152.
5. Carson, S. D. (2004). Coxsackievirus and adenovirus receptor (CAR) is modified and shed in membrane vesicles. Biochemistry 43, 8136-8142.
6. Carson, S. D., Hobbs, J. T., Tracy, S. M. & Chapman, N. M. (1999). Expression of the coxsackievirus and adenovirus receptor in cultured human umbilical vein endothelial cells: regulation in response to cell density. J Virol 73, 7077-7079.
7. Chapman, N. M., Kim, K. S., Tracy, S., Jackson, J., Hofling, K., Leser, J. S., Malone, J. & Kolbeck, P. (2000). Coxsackievirus expression of the murine secretory protein interleukin-4 induces increased synthesis of immunoglobulin G1 in mice. J Virol 74, 7952-7962.
8. Cunningham, K. A., Chapman, N. M. & Carson, S. D. (2003). Caspase-3 activation and ERK phosphorylation during CVB3 infection of cells: influence of the coxsackievirus and adenovirus receptor and engineered variants. Virus Res 92, 179-186.
9. Domingo, E., Martin, V., Perales, C., Grande-Perez, A., Garcia-Arriaza, J. & Arias, A. (2006). Viruses as quasispecies: biological implications. Curr Top Microbiol Immunol 299, 51-82.
10. Excoffon, K. J. D. A., Gansemer, N., Traver, G. & Zabner, J. (2007). Functional effects of coxsackievirus and adenovirus receptor glycosylation on homophilic adhesion and adenoviral infection. J Virol 81, 5573-5578.
11. Feuer, R., Mena, I., Pagarigan, R., Slifka, M. K. & Whitton, J. L. (2002). Cell cycle status affects coxsackievirus replication, persistence, and reactivation in vitro. J Virol 76, 4430-4440.
12. Hofling, K, Tracy, S., Chapman, N., Kim, K. S. & Leser, J. S. (2000). Expression of an antigenic adenovirus epitope in a group B coxsackievirus. J Virol 74, 4570-4578.
13. Hsu, K. H., Lonberg-Holm, K., Alstein, B. & Crowell, R. L. (1988). A monoclonal antibody specific for the cellular receptor for the group B coxsackieviruses. J Virol 62, 1647-1652.
14. Kim, K. S., Tracy, S., Tapprich, W., Bailey, J., Lee, C. K., Kim, K., Barry, W. H. & Chapman, N. M. (2005). 5′-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA. J Virol 79, 7024-7041.
15. Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
16. Polacek, C., Ekstrom, J.-O., Lundgren, A. & Lindberg, A. M. (2005). Cytolytic replication of coxsackievirus B2 in CAR-deficient rhabdomyosarcoma cells. Virus Res 113, 107-115.
17. Raines, R. T., McCormick, M., Van Oosbree, T. R. & Mierendorf, R. C. (2000). The S.Tag fusion system for protein purification. Methods Enzymol 326, 362-376.
18. Reagan, K. J., Goldberg, B. & Crowell, R. L. (1984). Altered receptor specificity of coxsackievirus B3 after growth in rhabdomyosarcoma cells. J Virol 49, 635-640.
19. Schmidtke, M., Selinka, H.-C., Heim, A., Jahn, B, Tonew, M., Kandolf, R., Stelzner, A. & Zell, R. (2000). Attachment of coxsackievirus B3 variants to various cell lines: mapping of phenotypic differences in capsid protein VP1. Virology 275, 77-88.
20. Seidman, M. A., Hogan, S. M., Wendland, R. L., Worgall, S., Crystal, R. G. & Leopold, P. L. (2001). Variation in adenovirus receptor expression and adenovirus vector-mediated transgene expression at defined stages of the cell cycle. Mol Ther 4, 13-21.
21. Shafren, D. R., Williams, D. T. & Barry, R. D. (1997). A decay-accelerating factor-binding strain of coxsackievirus B3 requires the coxsackievirus-adenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cells. J Virol 71, 9844-9848.
22. She, R. C., Crist, G., Billetdeaux, E., Langer, J. & Petti, C. A. (2006). Comparison of multiple shell vial cell lines for isolation of enteroviruses: a national perspective. J Clin Virol 37, 151-155.
23. Shieh, J. T. C. & Bergelson, J. M. (2002). Interaction with decay-accelerating factor facilitates coxsackievirus B infection of polarized epithelial cells. J Virol 76, 9474-9480.
24. Tomko, R. P., Xu, R. & Philipson, L. (1997). HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci U S A 94, 3352-3356.
25. Tracy, S., Chapman, N. M. & Tu, Z. (1992). Coxsackievirus B3 from an infectious cDNA copy of the genome is cardiovirulent in mice. Arch Virol 122, 399-409.
26. Tracy, S., Drescher, K. M., Chapman, N. M., Kim, K. S., Carson, S. D., Pirruccello, S., Lane, P. H., Romero, J. R. & Leser, J. S. (2002). Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence. J Virol 76, 12097-12111.
27. Tu, Z., Chapman, N. M., Hufnagel, G., Tracy, S., Romero, J. R., Barry, W. H., Zhao, L., Curry, K. & Shapiro, B. (1995). The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the 5′ nontranslated region. J Virol 69, 4607-4618.
28. Zolotukhin, S., Potter, M., Hauswirth, W. W., Guy, J. & Muzyczka, N. (1996). A 'humanized' green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J Virol 70, 4646-4654.